The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients

Journal of the Medical Association of Thailand

Volumn 86, Issue 4, 2003, Pages 293-298

  Mootsikapun, Piroon ^a   Anunnatsiri, Siriluck ^a   Chetchotisakd, Ploenchan ^a   Choksawadphinyo, Kittiyaporn ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

AIDS; Cryptococcal Meningitis; Fluconazole; Itraconazole

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; ANTIFUNGAL AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FUNGAL MENINGITIS; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; THAILAND; TREATMENT OUTCOME; AIDS RELATED COMPLEX; COMPARATIVE STUDY; CRYPTOCOCCAL MENINGITIS; MIDDLE AGED;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUCONAZOLE; HUMANS; ITRACONAZOLE; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED;

EID: 0038123187     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515-48.
2. Chariyalertsak S, Sirisanthana T, Saengwonloey O, Nelson K. Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994-1998: Regional variation and temporal trends. Clin Infect Dis 2001; 32: 955-62.
3. Bennett JE, Dismukes WE, Duma RJ, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Eng J Med 1979; 301: 126-31.
4. Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B and fluconazole in the treatment of acute AIDS - associated cryptococcal meningitis. N Engl J Med 1992; 326: 83-9.
5. Sagg MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000; 30: 710-8.
6. Van Der Horst C, Saag MS, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997; 337: 15-21.
7. st National Conference on Human Retroviruses. Washington DC: American Society of Microbiology; 1994: 61.
8. Groll AH, Wash TJ. Azole: triazole. In: Yu VC, Merigan TC, Barriere SL, eds. Antimicrobial therapy and vaccine. Baltimore: Williams & Wilkins; 1999: 1158-70.
9. th Conference on Retroviruses and Opportunistic infections, Washington DC: Alexandria, VA; Westover Management Group; 1997: 120.